Vigintiphobia revisited

Pediatrics

Volumn 115, Issue 6, 2005, Pages 1747-1753

  Watchko, Jon F ^a,b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Breastfeeding; Genetics; Hyperbilirubinemia; Kernicterus

Indexed keywords

BILIRUBIN BLOOD LEVEL; BREAST FEEDING; BREAST MILK; FAMILY COUNSELING; FOLLOW UP; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENOTYPE; HETEROZYGOSITY; HUMAN; HYPERBILIRUBINEMIA; INCIDENCE; JAUNDICE; KERNICTERUS; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; VIGINTIPHOBIA; BLOOD; CRIGLER NAJJAR SYNDROME; DEHYDRATION; DIFFERENTIAL DIAGNOSIS; EXCHANGE BLOOD TRANSFUSION; GENETICS; GILBERT DISEASE; HEMOLYTIC ANEMIA; IATROGENIC DISEASE; MUTATION; NEWBORN; NEWBORN HEMOLYTIC DISEASE; NEWBORN JAUNDICE; PHOTOTHERAPY; PRACTICE GUIDELINE; REFERENCE VALUE; RHESUS ISOIMMUNIZATION; UNITED STATES;

BILIRUBIN; BILIRUBIN URIDINE DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; BILIRUBIN URIDINE-DIPHOSPHOGLUCURONOSYL TRANSFERASE 1A1; GLUCURONOSYLTRANSFERASE;

ANEMIA, HEMOLYTIC; BILIRUBIN; BREAST FEEDING; CRIGLER-NAJJAR SYNDROME; DEHYDRATION; DIAGNOSIS, DIFFERENTIAL; ERYTHROBLASTOSIS, FETAL; EXCHANGE TRANSFUSION, WHOLE BLOOD; GENETIC PREDISPOSITION TO DISEASE; GILBERT DISEASE; GLUCURONOSYLTRANSFERASE; HUMANS; IATROGENIC DISEASE; INCIDENCE; INFANT, NEWBORN; JAUNDICE, NEONATAL; KERNICTERUS; MUTATION; PRACTICE GUIDELINES; REFERENCE VALUES; RH ISOIMMUNIZATION; ULTRAVIOLET THERAPY; UNITED STATES;

EID: 27744446527     PISSN: 00314005     EISSN: 00314005     Source Type: Journal    
DOI: 10.1542/peds.2004-1748     Document Type: Review

References (100)

1. Watchko JF, Oski FA. Bilirubin 20 mg/dL = vigintiphobia. Pediatrics. 1983;71:660-663
2. Newman TB, Maisels MJ. Does hyperbilirubinemia damage the brain of health full-term infants? Clin Perinatol. 1990;17:331-358
3. Newman TB, Maisels MJ. Evaluation and treatment of jaundice in the term newborn: a kinder, gentler approach. Pediatrics. 1992;89:809-818
4. Newman TB, Klebanoff MA. Neonatal hyperbilirubinemia and long-term outcome: another look at the Collaborative Perinatal Project. Pediatrics. 1993;92:651-657
5. American Academy of Pediatrics, Provisional Committee for Quality Improvement and Subcommittee on Hyperbilirubinemia. Practice parameter: management of hyperbilirubinemia in the healthy term newborn [published correction appears in Pediatrics. 1995;95:458-461]. Pediatrics. 1994;94:558-562
6. Brown AK, Johnson LH. Loss of concern about jaundice and the reemergence of kernicterus in full term infants in the era of managed care. In: Fanafoff AA, Klaus MH, eds. Yearbook of Neonatal and Perinatal Medicine. St Louis, MO: Mosby-Year Book; 1996:xvii-xxxx
7. Johnson LH, Bhutani VK, Brown AK. System-based approach to management of neonatal jaundice and prevention of kernicterus. J Pediatr. 2002;140:396-403
8. Brown AK. Kernicterus: past, present, and future. NeoReviews. 2003;4:e33-e40
9. Mollison PL, Cutbush M. A method for measuring the severity of a series of cases of hemolytic disease of the newborn. Blood. 1951;6:777-788
10. Hsai DY, Allen FH, Gellis SS, Diamond LK. Erythroblastosis fetalis, VIII: studies of serum bilirubin in relation to kernicterus. N Engl J Med. 1952;247:668-671
11. Hsai DY, Gellis SS. Studies on erythroblastosis due to ABO incompatibility. Pediatrics. 1954;13:503-510
12. Allen FH, Diamond LK. Erythroblastosis Fetalis. Boston, MA: Little, Brown; 1958:56-57,120
13. Gellis SS: Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1953:285-289
14. Brown AK, Zuelzer WW. Studies in hyperbilirubinemia, I: hyperbilirubinemia of the newborn unrelated to isoimmunization. Am J Dis Child. 1957;93:263-273
15. Killander A, Muller-Eberhard U, Sjolin S. Indications for exchange transfusion in newborn infants with hyperbilirubinemia not due to Rh immunization. Acta Paediatr Scand. 1960;49:377-390
16. Killander A, Michaelsson M, Muller-Eberhard U, Sjolin S. Hyperbilirubinemia in full term infants: a follow-up study. Acta Paediatr Scand. 1963;52:481-484
17. Gellis SS. Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1961:30, 36
18. Gellis SS. Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1962:34
19. Gellis SS. Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1967:37
20. Gellis SS. Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1975:32-33
21. Holmes GE, Miller JB, Smith EE. Neonatal bilirubinemia in production of long-term neurologic deficits. Am J Dis Child. 1968;116:37-43
22. Bengtsson B, Verneholt J. Follow-up study of hyperbilirubinemia in healthy, full-term infants without isoimmunization. Acta Paediatr Scand. 1974;63:70-80
23. Gellis SS. Year Book of Pediatrics. Chicago, IL: Year Book Medical Publishers; 1970:427
24. Valaes T. Bilirubin toxicity: the problem was solved a generation ago. Pediatrics. 1992;89:819-821
25. Wennberg RP. Bilirubin recommendations present problems: new guidelines simplistic and untested. Pediatrics. 1992;89:821-822
26. Merenstein GB. "New" bilirubin recommendations questioned. Pediatrics. 1992;89:822-823
27. Poland RL. In search of a "gold standard" for bilirubin toxicity. Pediatrics. 1992;89:823-824
28. Cashore WJ. Hyperbilirubinemia: should we adopt a new standard of care? Pediatrics. 1992;89:824-826
29. Gartner LM. Management of jaundice in the well baby. Pediatrics. 1992;89:826-827
30. Brown AK, Seidman DS, Stevenson DK. Jaundice in healthy, term neonates: do we need new action levels or new approaches? Pediatrics. 1992;89:827-829
31. Johnson L. Yet another expert opinion on bilirubin toxicity! Pediatrics. 1992;89:829-831
32. Johnson L, Bhutani VK. Guidelines for management of the jaundiced term and near-term infant. Clin Perinatol. 1998;25:555-574
33. Bhutani VK, Johnson LH. Kernicterus: lessons for the future from a current tragedy. NeoReviews. 2003;4:e30-e32
34. Davidson L, Thilo EH. How to make kernicterus a "never event." NeoReviews. 2003;4:e308-e314
35. American Academy of Pediatrics, American College of Obstetricians and Gynecologists. Guidelines for Perinatal Care. 3rd ed. Elk Grove Village, IL: American Academy of Pediatrics; 1992:108-109
36. Finlay HV, Tucker SM. Neonatal plasma bilirubin chart. Arch Dis Child. 1978;53:90-91
37. Dodd KL. Neonatal jaundice: a lighter touch. Arch Dis Child. 1993;68:529-533
38. Panagopoulos G, Valaes T, Doxiadis SA. Morbidity and mortality related to exchange transfusions. J Pediatr. 1969;74:247-254
39. Jackson JC. Adverse events associated with exchange transfusion in healthy and ill newborns. Pediatrics. 1997;99(5). Available at: www.pediatrics.org/cgi/content/full/99/5/e7
40. Patra K, Storfer-Isser A, Siner B, Moore J, Hack M. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr. 2004;144:626-631
41. Chima RS, Johnson LH, Bhutani BK. Evaluation of adverse events due to exchange transfusions in term and near-term newborns [abstract]. Pediatr Res. 2001;49:324A
42. Keenan WJ, Novak KK, Sutherland JM, Bryla DA, Fetterly KL. Morbidity and mortality associated with exchange transfusion. Pediatrics. 1985;75(suppl):422- 426
43. Ip S, Chung M, Kulig J, et al. An evidence-based review of important issues concerning neonatal hyperbilirubinemia. Pediatrics. 2004;114(1). Available at: www.pediatrics.org/cgi/content/full/114/1/e130
44. Maisels MJ. Is exchange transfusion for hyperbilirubinemia in danger of becoming extinct [abstract]? Pediatr Res. 1999;45:210A
45. Watchko JF. Exchange transfusion in the management of neonatal hyperbilirubinemia. In: Maisels MJ, Watchko JF, eds. Neonatal Jaundice. Amsterdam, The Netherlands: Harwood Academic Publishers; 2000:169-176
46. Cabana MD, Rand CS, Powe NR. Why don't physicians follow clinical practice guidelines? A framework for improvement. JAMA. 1999;282:1458-1465
47. Christakis DA, Rivara FP. Pediatrician's awareness of and attitudes about four clinical practice guidelines. Pediatrics. 1998;101:825-830
48. Atkinson LR, Escobar GJ, Takayama JL, Newman TB. Phototherapy use in jaundiced newborns in a large managed care organization: do clinicians adhere to the guidelines? Pediatrics. 2003;111(5). Available at: www.pediatrics.org/cgi/ content/full/111/5/e555
49. McMillan DD, Lockyer JM, Magnan L, Akierman A, Parboosingh JT. Effect of educational program and interview on adoption of guidelines for the management of neonatal hyperbilirubinemia. Can Med Assoc J. 1991;144:707-712
50. Lannon C, Stark AR. Closing the gap between guidelines and practice: ensuring safe and healthy beginnings. Pediatrics. 2004;114:494-496
51. Penn AA, Enzmann DR, Hahn JS, Stevenson DK. Kernicterus in a full term infant. Pediatrics. 1994;93:1003-1006
52. MacDonald M. Hidden risks: early discharge and bilirubin toxicity due to glucose-6-phosphate dehydrogenase deficiency. Pediatrics. 1995;96:734-738
53. Maisels MJ, Newman TB. Kernicterus in otherwise healthy, breast-fed term newborns. Pediatrics. 1995;96:730-733
54. Washington EC, Ector W, Abbound M, Ohning B, Holden K. Hemolytic jaundice due to G6PD deficiency causing kernicterus in a female newborn. South Med J. 1995;88:776-779
55. Johnson L, Brown AK. A pilot registry for acute and chronic kernicterus in term and near-term infants. Pediatrics. 1999;104(suppl):736
56. Ebbesen F. Recurrence of kernicterus in term and near-term infants in Denmark. Acta Paediatr. 2000;89:1-5
57. Harris MC, Bernbaum JC, Polin JR, Zimmerman R, Polin RA. Developmental follow-up of breast-fed term and near term infants with marked hyperbilirubinemia. Pediatrcs. 2001;107:1075-1080
58. American Academy of Pediatrics, Subcommittee on Neonatal Hyperbilirubinemia. Neonatal jaundice and kernicterus. Pediatrics. 2001;108:763-765
59. Ip S, Glicken S, Kulig J, O'Brien R, Sege R. Management of Neonatal Hyperbilirubinemia: Evidence Report/Technology Assessment. Prepared by Tufts-New England Medical Center Evidence-Based Practice Center under contract 290-97-0019. Rockville, MD: Agency for Healthcare Research and Quality; 2003
60. Joint Commission on Accreditation of Healthcare Organizations. Sentinel Event Alert: Kernicterus Threatens Healthy Newborns. 2001. Available at: www.jcaho.org/about+us/news+letters/sentinel+event+alert/sea_18.htm
61. Maisels MJ, Newman TB. Jaundice in full-term and near-term babies who leave the hospital within 36 hours: the pediatrician's nemesis. Clin Perinatol. 1998;25:295-302
62. Cui Y, Konig J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem. 2001;276:9626-9630
63. Huang MJ, Kua KE, Teng HC, Tang KS, Weng HW, Huang CS. Risk factors for severe hyperbilirubinemia in neonates. Pediatr Res. 2004;56:682-689
64. Watchko JF. Genetics and the risk of neonatal hyperbilirubinemia. Pediatr Res. 2004;56:677-678
65. Kaplan M, Hammerman C, Maisels MJ. Bilirubin genetics for the nongeneticist: hereditary defects of neonatal bilirubin conjugation. Pediatrics. 2003;111:886-893
66. Watchko JF, Daood MJ, Biniwale M. Understanding neonatal hyperbilirubinemia in the era of genomics. Semin Neonatol. 2002;7:143-152
67. American Academy of Pediatrics. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics. 2004;114:297-316
68. Kivlahan C, James EJP. The natural history of neonatal jaundice. Pediatrics. 1984;74:364-370
69. Linn S, Schoenbaum SC, Monson RR, Rosner B, Stubblefiedl PG, Ryan KJ. Epidemiology of neonatal hyperbilirubinemia. Pediatrics. 1985;75:770-774
70. Maisels MJ, Gifford K, Antle CE, et al. Normal serum bilirubin levels in the newborn and the effect of breast feeding. Pediatrics. 1986;78:837-843
71. Schneider AP. Breast milk jaundice in the newborn: a real entity. JAMA. 1986;255:3270-3274
72. Hansen TWR. Bilirubin production, breast-feeding and neonatal jaundice. Acta Paediatr. 2001;90:716-723
73. Nielsen HE, Haase P, Blaabjerg J, Stryhn H, Hilden J. Risk factors and sib correlation in physiological neonatal jaundice. Acta Paediatr Scand. 1987;76:504-511
74. Rubaltelli FF. Unconjugated and conjugated bilirubin pigments during perinatal development, IV: the influence of breast-feeding on neonatal hyperbilirubinemia. Biol Neonate. 1993;64:104-109
75. De Carvalho M, Klaus MH, Merkatz RB. Frequency of breastfeeding and serum bilirubin concentration. Am J Dis Child. 1982;136:737-738
76. Yamauchi Y, Yamanouchi I. Breast-feeding frequency during the first 24 hours after birth in full term neonates. Pediatrics. 1990;86:171-175
77. Takimoto M, Matsuda I. β-Glucuronidase activity in the stool of newborn infant. Biol Neonate. 1972;18:66-70
78. Gourley GR. Perinatal bilirubin metabolism. In: Gluckman PD, Heymann MA, eds. Perinatal and Pediatric Pathophysiology: A Clinical Perspective. Boston, MA: Hodder and Stoughton; 1993:437-439
79. Poland RD, Odell GB. Physiologic jaundice: the enterohepatic circulation of bilirubin. N Engl J Med. 1971;284:1-6
80. Gartner LM, Lee K-S, Vaisman S, et al. Development of bilirubin transport and metabolism in the newborn rhesus monkey. J Pediatr. 1977;90:513-531
81. Gartner U, Goeser T, Wolkoff AW. Effect of fasting on the uptake of bilirubin and sulfobromophthalein by the isolated perfused rat liver. Gastroenterology. 1997;113:1707-1713
82. Fevery J. Fasting hyperbilirubinemia: unraveling the mechanism involved. Gastroenterology. 1997;113:1798-1799
83. Bertini G, Carlo C, Tronchin M, Rubaltelli FF. Is breastfeeding really favoring early neonatal jaundice? Pediatrics. 2001;107(3). Available at: www.pediatrics.org/cgi/content/full/107/3/e41
84. Maisels MJ: Epidemiology of neonatal jaundice. In: Maisels MJ, Watchko JF, eds. Neonatal Jaundice. Amsterdam, The Netherlands: Harwood Academic Publishers; 2000:37-49
85. Stevenson DK, Bortoletti AL, Ostrander CR, et al. Pulmonary excretion of carbon monoxide in the human infant as an index of bilirubin production, IV: effects of breast-feeding and caloric intake in the first postnatal week. Pediatrics. 1980;65:1170-1172
86. Hintz SR, Gaylord TD, Oh W, Fanaroff AA, et al. Serum bilirubin levels at 72 hours by selected characteristics in breastfed and formula-fed term infants delivered by cesarean section. Acta Paediatr. 2001;90:776-781
87. Monaghan G, McLellan A, McGeehan A. Gilbert's syndrome is a contributory factor in prolonged unconjugated hyperbilirubinemia of the newborn. J Pediatr. 1999;134:441-446
88. Maruo Y, Nishizawa K, Sato H, Doida Y, Shimada M. Association of neonatal hyperbilirubinemia with bilirubin UDP-glucuronosyltransferase polymorphism. Pediatrics. 1999;103:1224-1227
89. Crigler JF, Najjar VA. Congenital familial nonhemolytic jaundice with kernicterus. Pediatrics. 1952;10:169-180
90. Bosma PJ, Roy Chowdhury J, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Engl J Med. 1995;333:1171-1175
91. Kadakol A, Sappal BS, Ghosh SS, et al. Interaction of coding region mutations and the Gilbert-type promoter abnormality of the UGT1A1 gene causes moderate degrees of unconjugated hyperbilirubinemia and may lead to neonatal kernicterus. J Med Genet. 2001;38:244-249
92. Kaplan M, Renbaum P, Levy-Lahad E, Hammerman C, Lahad A, Beutler E. Gilbert syndrome and glucose-6-phosphate dehydrogenase deficiency: a dose-dependent genetic interaction crucial to neonatal hyperbilirubinemia. Proc Natl Acad Sci USA. 1997;94:12128-12132
93. Iolascon A, Faienza MF, Moretti A. UGT1 promoter polymorphism accounts for increased neonatal appearance of hereditary spherocytosis. Blood. 1998;91:1093
94. Kaplan M, Hammerman C, Renbaum P, Klein G, Levy-Lahad E. Gilbert's syndrome and hyperbilirubinemia in ABO-incompatible neonates. Lancet. 2000;356:652-653
95. Chalasani N, Roy Chowdhury N, Roy Chowdhury J, Boyer TD. Kernicterus in an adult who is heterozygous for Crigler-Najjar syndrome and homozygous for Gilbert-type genetic defect. Gastroenterology. 1997;112:2099-2103
96. Ciotti M, Chen F, Rubaltelli FF, Owens IS. Coding and a TATA box mutation at the bilirubin UDP-glucuronosyl transferase gene cause Crigler-Najjar syndrome type I disease. Biochim Biophys Acta. 1998;1407:40-50
97. Yamamoto K, Soeda Y, Kamisako T, et al. Analysis of bilirubin uridine 5′-diphosphate (UDP)-glucuronosyltransferase gene mutations in seven patients with Crigler-Najjar syndrome type II. J Hum Genet. 1998;43:111-114
98. Huang CS, Chang PF, Huang MJ, Chen ES, Chen WC. Glucose-6-phosphate dehydrogenase deficiency, the UDP-glucuronosyltransferase 1A1 gene, and neonatal hyperbilirubinemia. Gastroenterology. 2002;123:127-133
99. Newman TB, Escobar GJ, Gonzalez VM, Armstrong MA, Gardner MN, Folck BF. Frequency of neonatal bilirubin testing and hyperbilirubinemia in a large health maintenance organization. Pediatrics. 1999;104:1198-1203
100. Lee KS, Perlman M, Ballantyne M, Elliot I, To T. Association between duration of neonatal hospital stay and readmission rate. J Pediatr. 1995;127:758-766